Apple wins antitrust case in China over app store fees; Temu is now subject to stricter EU online content rules; and Record Chinese investments flow into Mexico and Vietnam amid Western trade tensions.
Data security risk assessments are required for data processing activities by key data and core data handlers in the industry and information technology sector. Requirements applicable to AI service providers in respect of the security of data sources are set forth. The shareholders of a listed company may not lend shares through refinancing or short sell shares of the company during the lockup period.
Western companies are investing in Chinese biotech even amid continued geopolitical tension between China and the West and decreasing appetite for foreign investment in China; Two lithium battery part manufacturers, Capchem and Kedaliplan, plan to build factories in the U.S. to avoid hefty lithium battery tariffs; and Chinese pharma firm Asymchem to take over U.K. Pfizer plant.
Shanghai FTZ expedites cross-border transfer of specified data; CBP investigation finds no substantial evidence of evasion by CIE; and Another Chinese EV SPAC merger is in the pipeline but EU tariffs threaten the business.
Shanghai specifies record filing procedures for AI services. The People's Court Case Repository is made available to the general public. A branch of a bank may be allowed to sign an insurance agency agreement.
Successful U.S. IPO of Chinese EV brand suggests rising investor confidence, but regulatory risks still loom; Burberry wins trademark infringement and unfair competition lawsuit; and China proposes guidelines to it's lithium battery sector amid overcapacity concerns.
Tests for the Greater Bay Area cross-border data verification platform start in the financial industry; Beijing Internet Court decides case to protect natural voices modified by AI; and Chinese mining companies eye opportunities as BHP Group offers to acquire rival
The release of goods and determination of customs duty amounts may be carried out separately. Procedures are facilitated for marketing of domestically produced foreign pharmaceuticals. Government procurement may invite a supplier to cooperate in research and development.
